News | May 20, 2025
Crosslay Remedies acquires land adjacent to Max Super Speciality Hospital, Vaishali
CRL shall invest another Rs. 200 crore for creation of additional beds
CRL shall invest another Rs. 200 crore for creation of additional beds
EBITDA for the period rose by 23.2% to Rs. 3,797 million
Indraprastha Medical Corporation has reported total income of Rs. 340.10 crores during the period ended March 31, 2025
The company has posted net profit of Rs. 485.62 crores for the Financial Year ended March 31, 2025
In Q4 FY25, our pharmaceutical business reported revenue growth of 20% to Rs 351 crore and EBIT growth of 65% to Rs 55 croe, on QoQ basis
Shilpa Pharma Lifesciences, Unit-1, received EIR from USFDA
She has held senior positions at Coca-Cola in China and PepsiCo in India
The company has posted net profit of Rs. 1,414.44 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 30.53 crores for the Financial Year ended March 31, 2025
The company has posted net profit of Rs. 0.54 crores for the Financial Year ended March 31, 2025
Subscribe To Our Newsletter & Stay Updated
